Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
65
NVSEF Quote, Financials, Valuation and Earnings
Last price:
$111.00
Seasonality move
:
5.79%
Day range:
$111.00 - $111.00
52-week range:
$90.24 - $123.55
Dividend yield:
3.58%
P/E ratio:
18.88x
P/S ratio:
4.37x
P/B ratio:
4.98x
Volume:
1.1K
Avg. volume:
89.5K
1-year change:
11%
Market cap:
$219.2B
Revenue:
$51.7B
EPS (TTM):
$5.88
Novartis AG Number of Institutional Trades
Novartis AG Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$11.2B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$35.2B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Novartis AG Institutional Ownership
-
What Percentage Of NVSEF Is Owned by Institutions?
-- of NVSEF is owned by institutions.
-
How Many Institutions Own NVSEF Shares?
Novartis AG stock is owned by 0 institutional shareholders at this time.
-
Have Institutions Been Buying NVSEF Stock?
Yes, institutions have bought 59.5M shares of NVSEF in the last quarter.
-
Have Institutions Been Selling NVSEF Stock?
Yes, institutions have sold 276.7M shares of NVSEF over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
